Poloni F, Romagnoli G, Cianfriglia M, Felici F
Laboratorio di Immunologia, Istituto Superiore di Sanità, Rome, Italy.
Int J Cancer. 1995 May 29;61(5):727-31. doi: 10.1002/ijc.2910610522.
To identify an MC57 epitope which is more efficiently expressed on inactivated forms of P-glycoprotein we utilized peptide libraries displayed on filamentous phage. Using this technology, we selected specific phage clones blocking the binding of the murine monoclonal (MAb) MC57 with live human multi-drug-resistant (MDR) cells, and sequenced and analyzed their DNA. The results we obtained indicate that MAb MC57 epitope could be formed by 2 regions localized on the predicted fourth and sixth extracellular loops of the current 12-transmembrane-domain model predicted for MDR1-P-glycoprotein. Surprisingly, a third region, defined by residues 800-807 of the MDR1-P-glycoprotein sequence and postulated to be intracellular, was also identified as a putative part of the MC57 epitope. This finding adds weight to the interesting hypothesis that a P-glycoprotein structure different from the current model may exist.
为了鉴定一种在P-糖蛋白失活形式上更高效表达的MC57表位,我们利用了丝状噬菌体展示的肽库。利用这项技术,我们选择了能够阻断鼠单克隆抗体(MAb)MC57与活的人多药耐药(MDR)细胞结合的特定噬菌体克隆,并对其DNA进行了测序和分析。我们获得的结果表明,MAb MC57表位可能由位于目前预测的MDR1-P-糖蛋白12跨膜结构域模型的第四和第六个细胞外环上的2个区域形成。令人惊讶的是,由MDR1-P-糖蛋白序列的800-807位残基定义且假定位于细胞内的第三个区域,也被鉴定为MC57表位的假定部分。这一发现进一步支持了可能存在不同于当前模型的P-糖蛋白结构这一有趣假说。